Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing dinoprostone (medicinal product) |
Is a |
Prostaglandin E>1< preparation (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing dinoprostone (medicinal product) |
Is a |
Medicinal product acting as abortifacient agent (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing dinoprostone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Prostaglandin E>1< preparation (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing dinoprostone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dinoprostone (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Product containing dinoprostone (medicinal product) |
Is a |
Oxytocic preparation |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing dinoprostone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Posterior pituitary hormone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing dinoprostone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Prostaglandin E1 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing dinoprostone (medicinal product) |
Is a |
Product containing prostaglandin (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing dinoprostone (medicinal product) |
Is a |
Medicinal product acting as oxytocic (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing dinoprostone (medicinal product) |
Is a |
Prostaglandin E>1< preparation (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing dinoprostone (medicinal product) |
Is a |
Product containing E series prostaglandin (product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Product containing dinoprostone (medicinal product) |
Plays role |
Oxytocic therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|